DPd is an option for pts of all ages, showing a promising response in this difficult-to-treat population
P895: DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND 17P DELETION: UPDATED ANALYSIS OF THE DEDALO PHASE II TRIAL
Rizzi, Rita;
2023-01-01
Abstract
DPd is an option for pts of all ages, showing a promising response in this difficult-to-treat populationFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
HemaSphere - 2023 - Montefusco.pdf
accesso aperto
Descrizione: Poster
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
173.57 kB
Formato
Adobe PDF
|
173.57 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
